ROCK SPRINGS CAPITAL MANAGEMENT LP – Inozyme Pharma, Inc. Transaction History
ROCK SPRINGS CAPITAL MANAGEMENT LP portfolio value:
$7.52M
portfolio value
ROCK SPRINGS CAPITAL MANAGEMENT LP quarter portfolio value change:
-43.82%
quarter
Inozyme Pharma, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +6.35% | 167.56K shares | -5.06M | $2.68 | 2.80M |
| Q2 2022 | share | Increase | +121.26% | 1.44M shares | 7.71M | $4.77 | 2.64M |
| Q1 2022 | share | Increase | +37.39% | 324.72K shares | -1.04M | $4.09 | 1.19M |
| Q4 2021 | share | Increase | +2.17% | 18.45K shares | -3.92M | $6.95 | 868.46K |
| Q3 2021 | share | Increase | +1.16% | 9.74K shares | -4.46M | $11.59 | 850.01K |
| Q2 2021 | share | Increase | +1.49% | 12.37K shares | -2.07M | $17.04 | 840.27K |
| Q1 2021 | share | Decrease | -0.32% | -2.64K shares | -750K | $19.8 | 827.9K |
| Q4 2020 | share | Decrease | -5.61% | -49.40K shares | -5.99M | $20.64 | 830.54K |
| Q3 2020 | share | Increase | 0.00% | 879.95K shares | 23.13M | $26.29 | 879.95K |